- Rating
- 2
- Confidence
- 1
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
-
WSCF estimates long-term dose-path responses when a continuous dose, covariates and short-term surrogates all evolve over time, fusing a short randomised study without the long-term outcome with a confounded observational cohort: a windowed sequential g-formula identifies the target (Theorems 1–2), per-window optimal-transport weights estimate the surrogate kernel (Theorem 3), a rollout bound is derived under a hard Jacobian constraint, which training encourages through a penalty (Theorem 5), and a generalisation bound collects them (Theorem 6).
-
Validation is by MISE over three replications on a tumour-growth synthetic cohort at six confounding strengths and two semi-synthetic cohorts (MIMIC-III, an industrial panel).
-
The setting is new, the identification chain is careful enough to check, and the paper corrects a flaw in the alignment theory it inherits.
-
The evidence does not yet carry the claims: the margins come with no paired uncertainty, two tables disagree on the same configuration, and no comparison matches the baselines on surrogate information and its use.
Critical strengths
A real and unexplored problem, with an identification argument that is careful enough to check.
- The setting is new relative to the compared literature and the identification argument can be followed step by step. Specifically, none of the surveyed methods (LEARN, G-Net, CRN, the surrogate-index line) handles time-varying continuous doses, longitudinal surrogates and time-varying confounding together.
The paper corrects a gap in the theory it builds on and states honestly what its own bounds do and do not cover.
-
The counterexample shows that a joint Wasserstein bound does not control the conditional one, contradicting the inequality stated by Theorem 2 of Yang et al. (2024b), and Theorem 3 supplies the missing regularity. Specifically, a density on [0,1]² whose tilt in the surrogate direction flips sign at frequency n has joint W1 → 0 while the integrated conditional W1 stays at a/(3π).
-
The paper is candid about its own limits. Specifically, it says Lemma 4 is "a necessity argument only", that "the penalty is not the condition", and, before Theorem 6, that the generalisation bound excludes weighting error.
Critical weaknesses
The margins over the strongest baselines come without paired uncertainty, and the paper disagrees with itself about the same configuration.
-
The improvements over the strongest baselines lack paired uncertainty estimates, so their robustness across replications is not established. Specifically, against the strongest non-WSCF baseline in each column of Table 1, WSCF improves MISE by 0.005 (βU = 1.0) to 0.041 (MIMIC-III), with per-method standard deviations from three replications of 0.022–0.052 for WSCF and up to 0.090 for baselines; a single method's SD is not the uncertainty of a paired difference, and no paired interval is given.
-
Two tables give different numbers and a different module ranking for one configuration. Specifically, at βU = 3.5 Table 1 gives WSCF 0.504, noOT 0.617 and noIPM 0.506, whereas Table 3 gives 0.479, 0.548 and 0.598, so which module matters changes between tables.
The comparison is not like-for-like, and the strongest natural baseline is missing.
-
No comparison is matched on surrogate information and its use. Specifically, RMSN, CRN, G-Net and DCRN are run "without surrogate pivot" and land at 3.08–3.18 at βU = 3.5, while the paper's own WSCF-noSurrogate ablation scores 2.965; the closeness suggests that how surrogates are used is a major uncontrolled factor, although the methods also differ in model, training and interface, so the gap cannot be attributed to input alone.
-
The baselines that would isolate the contribution are never run. Specifically, G-Net or CRN given the surrogate history as a time-varying covariate and simulated forward is absent, as is a WSCF variant whose surrogate kernel is fitted on the trial alone (n1 = 1500), which is what the OT reweighting must beat.
Questions for authors
See weaknesses.
Responses to S5YT
Thank you for your comments and suggestions. Please find below point-by-point responses.
Most favor WSCF, except at βU=1, where Longitudinal-S is not significantly different: it uses longitudinal surrogates and debiases time-varying covariates, but not U. Similarly, paired 95% CIs for MISE(WSCF-noOT)−MISE(WSCF) are (-0.049,0.034) at βU=1 and (0.032,0.166) at 3.5.
W2[Table discrepancies]: We apologize for the unclear details. We reran full, noOT, noIPM, noJSR and None from Table3 on a different set of 6 shared seeds for internally consistent ablation comparisons; the new results differ from Table1.
W3[w/ vs w/t S]: We apologize for the unclear interpretation of the surrogate pivot's contribution and for overlooking module differences in the comparisons with temporal models (CRN, G-Net, etc.) in Table1. At βU=3.5, we controlled this factor by rerunning all temporal methods previously evaluated without S, now with (w/ S) and without (w/t S) surrogate history, across 6 seeds. We report mean paired MISE differences (95% CIs), MISE(method)−MISE(WSCF).
The gap cannot be attributed to input alone, even when surrogate information is matched. Adding S improves G-Net and WSCF but introduces error propagation, causing CRN and RMSN to suffer from variance explosion, while DCRN's design and our JSR penalty suppress this issue, as illustrated in our Related Work section. WSCF still outperforms the other methods with S, showing that JSR, U debiasing, and the window structure also matter.
With the same outcome model and kernel-training budget, WSCF achieved lower MISE than the variant whose surrogate kernel was fitted on the trial data alone. This comparison supports adding density-ratio-weighted observational transitions to the trial data.